kaempferol rhamnoside hamilelikte güvenli mi?

Related ingredients

Frequently asked questions

kaempferol rhamnoside hamilelikte güvenli mi?

No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for kaempferol 3‑rhamnoside (Afzelin, CAS 482-39-3). ECHA substance information shows only company notifications for irritation endpoints (no H360/H361 harmonised classification). Peer‑reviewed literature for this compound reports pharmacology/toxicity studies (neuroprotective, metabolic) but no reproductive or teratology data, so there is no evidence of reproductive hazard. Low dermal/systemic absorption is expected for a polar flavonol glycoside in topical use, so exposure from normal cosmetic topical use is judged low but measurable. Sources: ECHA substance page, PubChem entry, PubMed studies.

kaempferol rhamnoside emzirirken güvenli mi?

No data indicate reproductive or lactation-specific toxicity or endocrine disruption for afzelin. With low expected dermal absorption for the glycoside, maternal systemic exposure from cosmetic topical use would likely be low; therefore transfer to breastmilk is unlikely but not studied.

kaempferol rhamnoside bebek cildi için güvenli mi?

No infant-specific safety or developmental toxicity data were found. The compound is a flavonol glycoside (polar) and not known to be a developmental toxicant; hazard is therefore scored 0. Because infant skin has an immature barrier and higher surface‑area‑to‑weight, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2) to reflect higher potential per‑kg absorption if applied to baby skin.

VeriMom kaempferol rhamnoside nasıl puanlıyor?

VeriMom kaempferol rhamnoside'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.

Hamilelikte kaempferol rhamnoside yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.